Scenesse Side Effects
Generic name: afamelanotide
Note: This document contains side effect information about afamelanotide. Some of the dosage forms listed on this page may not apply to the brand name Scenesse.
Applies to afamelanotide: subcutaneous implant
Very common (10% or more): Implant skin reaction (21%)
Implant site reactions including implant site bruising, discoloration, erythema, hemorrhage, hypertrophy, irritation, nodule, pain, pruritus, swelling; injection site bruising and erythema; and expelled implant occurred more commonly in those receiving drug than those in the vehicle group (21% vs 10%). The most common implant site reaction reported in clinical studies was implant site discoloration (10%).
Skin hyperpigmentation included events of skin hyperpigmentation, pigmentation lip (subjects also had skin hyperpigmentation), and pigmentation disorder.[Ref]
Very common (10% or more): Nausea (19%)
Common (1% to 10%): Oropharyngeal pain
Common (1% to 10%): Fatigue[Ref]
Common (1% to 10%): Cough, respiratory tract infection[Ref]
1. "Product Information. Scenesse (afamelanotide)." Clinuvel, Inc., West Menlo Park, CA.
Medically reviewed by Drugs.com. Last updated on March 14, 2020.
More about Scenesse (afamelanotide)
- During Pregnancy
- Dosage Information
- Pricing & Coupons
- En Español
- Drug class: melanocortin receptor agonists
- FDA Approval History
Related treatment guides
Some side effects may not be reported. You may report them to the FDA.